APA

Olmos D., Arkenau H., Ang J. E., Ledaki I., Attard G., Carden C. P., Reid A. H. M., A'Hern R., Fong P. C., Oomen N. B., Molife R., Dearnaley D., Parker C., Terstappen L. W. M. M. & de Bono J. S. (20090319). Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Olmos D, Arkenau H-T, Ang J E, Ledaki I, Attard G, Carden C P, Reid A H M, A'Hern R, Fong P C, Oomen N B, Molife R, Dearnaley D, Parker C, Terstappen L W M M and de Bono J S. 20090319. Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Olmos D., Arkenau H., Ang J. E., Ledaki I., Attard G., Carden C. P., Reid A. H. M., A'Hern R., Fong P. C., Oomen N. B., Molife R., Dearnaley D., Parker C., Terstappen L. W. M. M. and de Bono J. S. (20090319). Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Olmos D, Arkenau H-T, Ang J E, Ledaki I, Attard G, Carden C P, Reid A H M, A'Hern R, Fong P C, Oomen N B, Molife R, Dearnaley D, Parker C, Terstappen L W M M and de Bono J S. Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. : Annals of oncology : official journal of the European Society for Medical Oncology. 20090319.